Summary of CORD BLOOD AMERICA, INC.

Item 4.02(a). Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

On May 11, 2012, the Company concluded, and the Audit Committee of the Board of Directors approved, that the previously filed unaudited consolidated financial statements contained in the Company's Quarterly Report on Form 10-Q for the three months and nine months ended September 30, 2011, originally filed with the Securities and Exchange Commission on November 14, 2011 (the "Original Filing"), should no longer be relied upon for the reasons set forth herein.

On May 25, 2012, the Company filed its 10-Q Amendment No. 1 for the three months and nine months ended September 30, 2011 (the "Amendment"). The Amendment amends and restates in its entirety the Original Filing. The Amendment was necessary to make a restatement in the quarter ended September 30, 2011 relating to the valuation of shares of the Company's common stock issued to Ironridge Global IV, Ltd. ("Ironridge"), an unrelated party, in connection with a settlement agreement the Company entered into in August 2011 in exchange for the transfer to Ironridge of certain claims against the Company in the amount of $260,695 due for services provided to the Company, which had not been paid. This restatement was necessary to recognize the value of such shares issued based on the fair value of the shares at the date of issuance as required by FASB ASC 505-50-30, Equity -Based Payments to Non-Employees. This restatement changes the reported net loss for the three and nine months ended September 30, 2011. Except as otherwise stated herein, no other information contained in the Original Filing has been updated by the Amendment, and no disclosures have been updated to reflect events that occurred at a later date.

The Company's authorized officers discussed the matters disclosed in this filing pursuant to Item 4.02(a) with the Company's independent registered public accounting firm.